12Oct
08Oct
Fundraiser being held in Ashley to give the gift of sight to Michael Stanek
For 30-year-old Michael Stanek , the chance to see is “overwhelmingly generous.” A fundraiser for Michael, who has been legally blind from birth, will be held from 1 to 8 p.m. Sunday at the Ashley Fireman’s Park on Ashley Street. “To think people would do something like that,” Michael said of the event organizers, expressing his gratefulness. Organizers look to raise $15,000 to allow Michael the chance to buy eSight — a high-tech eyewear device that enhances whatever the user is looking at...
08Oct
New technology helps legally blind Independence boy see
An Independence family is working to raise money so they can get new technology that will help a legally blind boy see. Corbin Wolfe has been through a lot in his seven years of life. He was a mini preemie, born weighing 1 pound, 14 ounces. He’s had 86 surgeries. “He’s a miracle,” his mom, Jennie Braden, said. Braden found eSight while researching online. The company came to Kansas City to do a demo, and the results stunned her.
07Oct
Troy students raise funds for blind professor who lost home in fire
Troy professor Joseph “Joey” Arnold got a phone call three weeks ago and was told that his home had burned to the ground. His insurance is paying for the house, but it won’t cover something very important to Arnold: a device that helps him see. Arnold is blind in one eye, and the other eye has a visual acuity of 20/800. The device, eSight, improves his acuity to 20/60. Students at Troy University, led by the Greek community, set up a fundraiser on...
05Oct
Why Corbus Pharmaceuticals Holdings Inc Shares Skyrocketed Today
Corbus Pharmaceuticals (NASDAQ: CRBP) is up 29% at 1:18 p.m. EDT after an analyst at Cantor Fitzgerald initiated coverage of the biotech with a buy rating. There's plenty to learn about Corbus Pharmaceuticals. The biotech only has one drug, resunab, but it's testing the anti-inflammatory drug in multiple indications: cystic fibrosis, systemic sclerosis, dermatomyositis, and lupus. Read more >>
22Sep
Skyline Medical and GLG Pharma Enter into Partnership to Develop Diagnostic Tests for Skyline’s STREAMWAY System
Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the signing of a partnership and exclusive reseller agreement with GLG Pharma, LLC (“GLG”). Read more >>
22Sep
AOBiome Announces First-of-its Kind Trial of Live Topical Bacterial Treatment for Acne
Leading skin microbiome company AOBiome announced today the launch of its Phase 2B trial using its first-in-class live bacteria to treat acne. Phase 2B marks the advancement from the company's successful Phase 1B/2A dose-ranging safety study, which resulted in no serious adverse events and no difference in adverse events between treatment and vehicle groups. Read more >>
21Sep
Professional athletic trainers adopt sam® Sport to accelerate injury recovery and reduce opioid use for pain management
ZetrOZ Systems, LLC, announced today that the company’s innovative FDA cleared wearable-active ultrasound device – called sam® Sport – is now used widely by professional athletic trainers and physiotherapists in the NFL, NBA, NHL, MLS, MLB and USA Teams. Read more >>
16Sep
Premama® Achieves 700% Record Growth, Continuing to Fuel the Emerging Maternity Wellness Category
Premama®, the first nationwide line of natural powdered drink mixes and soft chews to support complete maternity wellness from preconception through pregnancy and beyond, today announced a record retail expansion, experiencing rapid growth from 1,100 to 7,700 retail distribution points since April 2015 and a significant 360% growth in sales from August 2015 to August 2016. Spearheading maternity wellness as a retail category, Premama has pioneered industry awareness and consumer demand with products for the entire maternity journey.
14Sep